Irritable Bowel Syndrome Constipation Study – Ardelyx

Trial for Moderate to Severe Irritable Bowel Syndrome Constipation from Aredelyx.
Ehrhardt Clinical Research currently has openings for IBS Constipation from Aredelyx. This trial uses oral medication for subjects suffering from IBS Constipation.

Some General Patient Selection Criteria Include:

  • Male or female aged 18-75 at time of screening
  • Have been diagnosed with IBS constipation or chronic constipation
  • Are currently experiencing symptom such as less than 3 stools per week, bloating and abdominal pain
  • Cannot have diarrhea

Qualified Candidates May Receive:

  • Treatment by licensed and experience GI physician
  • Study provided medication
  • Compensation for time and travel

If you are interested in this trial, please call us at 816-318-8488 or email us at info@ecrtrials.com or complete the Volunteer Interest Form today.

Written by

Jody Ehrhardt